Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

BACKGROUND: To investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test. METHODS: CORVETTE-01 was a double-blind, randomized, placebo-controlled study (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wada, Tatsuhiko, Hibino, Makoto, Aono, Hiromi, Kyoda, Shunsuke, Iwadate, Yosuke, Shishido, Eri, Ikeda, Keisuke, Kinoshita, Nana, Matsuda, Yasuki, Otani, Sakiko, Kameda, Ryo, Matoba, Kenta, Nonaka, Miwa, Maeda, Mika, Kumagai, Yuji, Ako, Junya, Shichiri, Masayoshi, Naoki, Katsuhiko, Katagiri, Masato, Takaso, Masashi, Iwamura, Masatsugu, Katayama, Kazuhiko, Miyatsuka, Takeshi, Orihashi, Yasushi, Yamaoka, Kunihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240959/
https://www.ncbi.nlm.nih.gov/pubmed/37283627
http://dx.doi.org/10.3389/fmed.2023.1139046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240959/
https://www.ncbi.nlm.nih.gov/pubmed/37283627
http://dx.doi.org/10.3389/fmed.2023.1139046

Ejemplares similares